Emerging Technologies in Breast Cancer Imaging:
Is CESM the Answer?

IMPORTANT

The expiration date for this activity has been extended and the activity was re-released on January 19, 2017.

Accurate mammograms are limited in dense breasts where surrounding fibroglandular tissue decreases the view of lesions. Even when tumors are detected, the full extent of the disease may not be clearly visible. New advances in breast imaging technologies include the use of contrast-enhanced spectral mammography (CESM), a safe and effective screening tool for the potential detection and diagnosis of cancerous lesions. This series of 5 independent 1 hour accredited activities will discuss the use of this screening tool in clinical practice as it compares to other imaging technologies.

Each activity is worth:
1.00 AMA PRA Category 1 Credit(s)TM

PROGRAM FACULTY:

Clarisse Dromain, MD, PhD
Heat of Imaging Department
Gustave Roussy
Cancer Campus Grand Paris
Villejuif Cedex, France

Maxine S. Jochelson, MD
Director of Radiology
Breast and Imaging Center
Memorial Sloan Kettering Cancer Center
Associate Clinical Professor of Radiology
Weill-Cornell School of Medicine
New York, NY

Lydia Liao, MD, PhD, MPH
Director of Cooper Breast Imaging Centers
MD Anderson-Cooper Cancer Institute
Professor of Radiology
Cooper Medical School of Rowan University
Camden, NJ

Jordana Phillips, MD
Director
Breast Imaging Education in Radiology
Beth Israel Deaconess Medical Center
Instructor in Radiology
Harvard Medical School
Boston, MA

Provided by

This activity is supported by
an educational grant from
GE Healthcare